Zydus Wellness Ltd Q4 FY2025 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/1klz4n7tbdvrn5urqr3qh1i1.pdf

Key Takeaways


Segment & Brand Performance

Tarun Arora: "We want to be a stronger, larger science-based, high-performing product business with credible evidence of performance in 2 spaces."

Margin Trajectory & Cost Management

Tarun Arora: "I can't tie myself and say this is exactly what it is, and I'll change my guidance every time I face pressure. This is the intent, and our action is going to be guided by this intent."

Acquisitions & Capital Allocation

Tarun Arora: "We are not seeking acquisition for scale. That's one of the key tasks we did when we did with Kraft Heinz India acquisition."

Channel & Demand Dynamics

Tarun Arora: "it obviously helps democratize better, and therefore, be able to reach some new consumers"

New Initiatives & Portfolio Expansion


Guidance & Commitments

CommitmentSpecificsTimeline
EBITDA margin intentMove to 17%–18%Next 2–3 years
Gross margin improvementAnother couple of percentage pointsNext couple of years
Rite Bite cash EPS accretionCash EPS accretiveFY '26
Rite Bite growthContinue 25%+ CAGROngoing (tracking reasonably well)
A&P to salesOperate closer to 13% (+/-0.5%)No fixed date
I'm Lite portfolio shareAt least 15%–20% of sweeteners portfolioEventually
International businessDouble every 3 years, reach 8%–10% of portfolioNo fixed date
Revenue milestoneCross ₹5,000 crores3–5 years
Cash taxNo cash tax payoutFY '26 and FY '27
Acquisition strategyBolt-on only, ₹100–₹200 crore range, funded from internal accrualsOngoing

Key Metrics

MetricQ4 FY25
Consolidated net sales₹910.6 cr, +17% YoY
Volume growth13% YoY
FY25 revenue from operations₹2,691.2 cr, +16.2% YoY with 12.4% volume growth
Revenue CAGR from FY21 base~10%
Personal Care segment growth22.5% YoY for Q4; 33.4% for FY25
Food & Nutrition segment growth15.4% YoY for Q4; 13% for FY25
Gross margin expansion42 bps YoY in Q4; 168 bps for FY25; 361 bps over FY24 and FY25 combined
EBITDA₹190 cr, +17.1% YoY
Net profit after tax₹171.9 cr, +14.4% YoY
FY25 EBITDA₹379.7 cr, +23.2% YoY
FY25 net profit (excl. exceptional item and one-time deferred tax assets)₹341 cr, +30% YoY
EPS (FY25)₹54.52, up from ₹41.94 in FY24
Final dividend recommended₹6 per share (60% of face value ₹10), 20% increase over previous year
Stock split1:5, face value reducing from ₹10 to ₹2
Cash conversion from operations380 crore, 100% realization of EBITDA
Organized trade saliency (FY25)23% of sales; e-commerce 10%, non-trade 13%
Quick commerce share of e-commerce41%
Everyuth Scrub market share48.5%, +321.4 bps YoY (MAT March 2025)
Everyuth Peel-off market share77.7%, +6.1 bps YoY (MAT March 2025)
Everyuth overall facial cleansing market share7.7%, 5th position (MAT March 2025)
Nycil market share (prickly heat powder)33.8%, #1 position (MAT March 2025)
Glucon D market share (glucose powder)58.8% (MAT March 2025)
Sugar Free market share (sugar substitute)95.9% (MAT March 2025)
Rite Bite growth since acquisitionHigher than 50% over 4 months; margins positive, low single digits
Rite Bite historical CAGR25%+ over last 3 to 5 years
A&P to sales ratio target~13% (+/-0.5%), with room for 0.5% to 1% improvement
EBITDA margin target17% to 18% over next couple of years
Revenue aspiration₹5,000 cr benchmark, in 3 to 5 years
Cash tax payoutNil for FY26 and FY27; only deferred tax liability